These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 32911763)

  • 1. Lipidomic UPLC-MS/MS Profiles of Normal-Appearing White Matter Differentiate Primary and Secondary Progressive Multiple Sclerosis.
    Pousinis P; Ramos IR; Woodroofe MN; Cole LM
    Metabolites; 2020 Sep; 10(9):. PubMed ID: 32911763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent endothelial abnormalities and blood-brain barrier leak in primary and secondary progressive multiple sclerosis.
    Leech S; Kirk J; Plumb J; McQuaid S
    Neuropathol Appl Neurobiol; 2007 Feb; 33(1):86-98. PubMed ID: 17239011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective unbiased plasma lipidomic of progressive multiple sclerosis patients-identifies lipids discriminating those with faster clinical deterioration.
    Amatruda M; Petracca M; Wentling M; Inbar B; Castro K; Chen EY; Kiebish MA; Edwards K; Inglese M; Casaccia P
    Sci Rep; 2020 Sep; 10(1):15644. PubMed ID: 32973249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UPLC-QTOF-MS-Based Plasma Lipidomic Profiling Reveals Biomarkers for Inflammatory Bowel Disease Diagnosis.
    Guan S; Jia B; Chao K; Zhu X; Tang J; Li M; Wu L; Xing L; Liu K; Zhang L; Wang X; Gao X; Huang M
    J Proteome Res; 2020 Feb; 19(2):600-609. PubMed ID: 31821004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and laboratory features of primary progressive and secondary progressive MS.
    Bashir K; Whitaker JN
    Neurology; 1999 Sep; 53(4):765-71. PubMed ID: 10489038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinctive sphingolipid patterns in chronic multiple sclerosis lesions.
    Podbielska M; Szulc ZM; Ariga T; Pokryszko-Dragan A; Fortuna W; Bilinska M; Podemski R; Jaskiewicz E; Kurowska E; Yu RK; Hogan EL
    J Lipid Res; 2020 Nov; 61(11):1464-1479. PubMed ID: 32769146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenic Mechanisms Associated With Different Clinical Courses of Multiple Sclerosis.
    Lassmann H
    Front Immunol; 2018; 9():3116. PubMed ID: 30687321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid derived from progressive multiple sclerosis patients promotes neuronal and oligodendroglial differentiation of human neural precursor cells in vitro.
    Cristofanilli M; Cymring B; Lu A; Rosenthal H; Sadiq SA
    Neuroscience; 2013 Oct; 250():614-21. PubMed ID: 23876320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MOG-IgG in primary and secondary chronic progressive multiple sclerosis: a multicenter study of 200 patients and review of the literature.
    Jarius S; Ruprecht K; Stellmann JP; Huss A; Ayzenberg I; Willing A; Trebst C; Pawlitzki M; Abdelhak A; Grüter T; Leypoldt F; Haas J; Kleiter I; Tumani H; Fechner K; Reindl M; Paul F; Wildemann B
    J Neuroinflammation; 2018 Mar; 15(1):88. PubMed ID: 29554927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of lipid profiles of type 2 diabetes associated with hyperlipidemia using untargeted UPLC Q-TOF/MS-based lipidomics approach.
    Yan L; Han P; Man J; Tian Y; Wang F; Wang J
    Clin Chim Acta; 2021 Sep; 520():53-62. PubMed ID: 34077755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microglia and astroglia proliferation within the normal appearing white matter in histologically active and inactive multiple sclerosis.
    Nowacki P; Koziarska D; Masztalewicz M
    Folia Neuropathol; 2019; 57(3):249-257. PubMed ID: 31588711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection and quantification of regional cortical gray matter damage in multiple sclerosis utilizing gradient echo MRI.
    Wen J; Yablonskiy DA; Luo J; Lancia S; Hildebolt C; Cross AH
    Neuroimage Clin; 2015; 9():164-75. PubMed ID: 27330979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (1)H MR spectroscopy of the brain in multiple sclerosis subtypes with analysis of the metabolite concentrations in gray and white matter: initial findings.
    Sijens PE; Mostert JP; Oudkerk M; De Keyser J
    Eur Radiol; 2006 Feb; 16(2):489-95. PubMed ID: 16028056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of normal-appearing white and gray matter in patients with primary progressive multiple sclerosis: a diffusion-tensor magnetic resonance imaging study.
    Rovaris M; Bozzali M; Iannucci G; Ghezzi A; Caputo D; Montanari E; Bertolotto A; Bergamaschi R; Capra R; Mancardi GL; Martinelli V; Comi G; Filippi M
    Arch Neurol; 2002 Sep; 59(9):1406-12. PubMed ID: 12223026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous immunoglobulin in primary and secondary chronic progressive multiple sclerosis: a randomized placebo controlled multicentre study.
    Pöhlau D; Przuntek H; Sailer M; Bethke F; Koehler J; König N; Heesen C; Späth P; Andresen I
    Mult Scler; 2007 Nov; 13(9):1107-17. PubMed ID: 17623736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Vivo Detection of Diffuse Inflammation in Secondary Progressive Multiple Sclerosis Using PET Imaging and the Radioligand ¹¹C-PK11195.
    Rissanen E; Tuisku J; Rokka J; Paavilainen T; Parkkola R; Rinne JO; Airas L
    J Nucl Med; 2014 Jun; 55(6):939-44. PubMed ID: 24711650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of the HLA-DR region in clinical subgroups of multiple sclerosis and its influence on prognosis.
    McDonnell GV; Mawhinney H; Graham CA; Hawkins SA; Middleton D
    J Neurol Sci; 1999 May; 165(1):77-83. PubMed ID: 10426152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1H MRSI comparison of white matter and lesions in primary progressive and relapsing-remitting MS.
    Suhy J; Rooney WD; Goodkin DE; Capizzano AA; Soher BJ; Maudsley AA; Waubant E; Andersson PB; Weiner MW
    Mult Scler; 2000 Jun; 6(3):148-55. PubMed ID: 10871825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intra-voxel and inter-voxel coherence in patients with multiple sclerosis assessed using diffusion tensor MRI.
    Cercignani M; Bozzali M; Iannucci G; Comi G; Filippi M
    J Neurol; 2002 Jul; 249(7):875-83. PubMed ID: 12140672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression and genotyping studies implicate the interleukin 7 receptor in the pathogenesis of primary progressive multiple sclerosis.
    Booth DR; Arthur AT; Teutsch SM; Bye C; Rubio J; Armati PJ; Pollard JD; Heard RN; Stewart GJ;
    J Mol Med (Berl); 2005 Oct; 83(10):822-30. PubMed ID: 16075257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.